Skip to main content

Advertisement

SpringerLink
Log in

Variants of Guillain-Barré syndrome: low incidence but high impact

  • Short Commentary
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fisher CM (1956) An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia, areflexia). New Engl J Med 255:57–65

    Article  CAS  PubMed  Google Scholar 

  2. Frenzen P (2008) Economic cost of Guillain-Barré syndrome in the United States. Neurology 71:21–27

    Article  CAS  PubMed  Google Scholar 

  3. Godschalk PC, Heikema AP, Gilbert M, Komagamine T, Ang CW, Glerum J, Brochu D, Li J, Yuki N, Jacobs BC, van Belkum A, Endtz HP (2004) The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barré syndrome. J Clin Invest 114:1659–1665

    CAS  PubMed  Google Scholar 

  4. Goodyear CS, O’Hanlon GM, Plomp JJ, Wagner ER, Morrison I, Veitch J, Cochrane L, Bullens RW, Molenaar PC, Conner J, Willison HJ (1999) Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle–nerve preparations. J Clin Invest 104:697–708

    Article  CAS  PubMed  Google Scholar 

  5. Guillain G, Barré JA, Strohl A (1916) Sur un syndrome de radiculonévrite avec hyperalbuminose du liquide céphalo-rachidien sans réaction cellulaire. Remarques sur les caractères cliniques et graphiques des réflexes tendineux. Bull Soc Méd Hôp Paris 40

  6. Henderson R, Lawn N, Fletcher D, McClelland R, Wijdicks E (2003) The morbidity of Guillain-Barré syndrome admitted to the intensive care unit. Neurology 60:17–21

    CAS  PubMed  Google Scholar 

  7. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, Asbury AK, Blaser MJ, McKhann GM (1995) Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118:597–605

    Article  PubMed  Google Scholar 

  8. Hughes RA, Cornblath DR (2005) Guillain-Barré syndrome. Lancet 366:1653–1666

    Article  CAS  PubMed  Google Scholar 

  9. Kieseier BC, Kiefer R, Gold R, Hemmer B, Willison HJ, Hartung HP (2004) Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve 30:131–156

    Article  CAS  PubMed  Google Scholar 

  10. Lehmann HC, Kohne A, zu Horste GM, Kieseier BC (2007) Incidence of Guillain-Barré syndrome in Germany. J Peripher Nerv Syst 12:285

    Article  PubMed  Google Scholar 

  11. Lyu R, Chen S (2004) Acute multiple cranial neuropathy: a variant of Guillain-Barré syndrome? Muscle Nerve 30:433–436

    Article  PubMed  Google Scholar 

  12. McGrogan A, Madle G, Seaman H, de Vries C (2009) The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology 32:150–163

    Article  PubMed  Google Scholar 

  13. Ropper A (1994) Further regional variants of acute immune polyneuropathy. Bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal–cervical–brachial weakness. Arch Neurol 51:671–675

    CAS  PubMed  Google Scholar 

  14. Susuki K, Koga M, Hirata K, Isogai E, Yuki N (2009) A Guillain-Barré syndrome variant with prominent facial diplegia. J Neurol (this issue)

  15. Susuki K, Rasband MN, Tohyama K, Koibuchi K, Okamoto S, Funakoshi K, Hirata K, Baba H, Yuki N (2007) Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 27:3956–3967

    Article  CAS  PubMed  Google Scholar 

  16. Ter Bruggen J, van der Meché F, de Jager A, Polman C (1998) Ophthalmoplegic and lower cranial nerve variants merge into each other and into classical Guillain-Barré syndrome. Muscle Nerve 21:239–242

    Article  CAS  PubMed  Google Scholar 

  17. van Doorn PA, Ruts L, Jacobs BC (2008) Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 7:939–950

    Article  PubMed  Google Scholar 

  18. Willison HJ, Yuki N (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain 125:2591–2625

    Article  PubMed  Google Scholar 

  19. Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa K, Kobata T, Yamada M (2004) Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc Natl Acad Sci USA 101:11404–11409

    Article  CAS  PubMed  Google Scholar 

  20. Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, Ueda S, Kasama T, Ohnishi A, Hayashi S, Takahashi H, Kamijo M, Hirata K (2001) Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 49:712–720

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Heinrich-Heine-University, Moorenstrasse 5, 40225, Düsseldorf, Germany

    Helmar C. Lehmann & Hans-Peter Hartung

Authors
  1. Helmar C. Lehmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans-Peter Hartung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans-Peter Hartung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lehmann, H.C., Hartung, HP. Variants of Guillain-Barré syndrome: low incidence but high impact. J Neurol 256, 1909–1910 (2009). https://doi.org/10.1007/s00415-009-5253-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-009-5253-9

Keywords

Search

Navigation